Characterising MAFLD and MASH from hepatic ultrasound
Lead Applicant: Steve Margetts
May 2023
UK Keratinocyte Cancer Collaborative - Generating a Molecular Atlas for Skin Cancer
Lead Applicant: C Proby
May 2023
Defining stromal biology in the pathogenesis of oesophageal cancer to create a novel biomarker signature to aid diagnosis, prognosis, and treatment strategies
Lead Applicant: Mairi McLean
April 2023
Assessment of Il-1 beta and the inflammasome in patients with bronchiectasis and COPD
Lead Applicant: James D Chalmers
April 2023
Developing a KScan diagnostic for patient stratification of first line HCC therapies.
Lead Applicant: Andrew Williamson
April 2023
Validation of an ELISA assay for measurement of Charcot Leiden Crystals (CLC)
Lead Applicant: James D Chalmers
March 2023
Identifying novel treatment targets for bile acid diarrhoea through interrogation of targeted epithelial barrier disease mechanisms and discovery science proteomics in human gut organoid models
Lead Applicant: Mairi McLean
March 2023
Establishing the Dundee Brain Tumour Live Biorepository
Lead Applicant: Dr. Sourav Banerjee
February 2023
Using shotgun metagenomic sequencing to investigate the lung microbiome of individuals with chronic lung disease compared to patients without chronic lung disease
Lead Applicant: James D Chalmers
December 2022
Use of airway samples that are surplus to diagnostic requirements for optimisation of laboratory assays for measurement of inflammation and infection.
Lead Applicant: James D Chalmers
December 2022
Investigating the expression and function of LRRK2 in human gut organoid models
Lead Applicant: Mairi McLean
November 2022
Impact of airway mucus and inflammatory stimuli on permeability of pulmonary drugs into airway cells
Lead Applicant: James D Chalmers
November 2022
Genetics of leukocyte function in early respiratory infection
Lead Applicant: James D Chalmers
October 2022
Defects of the perinuclear actomyosin network in colorectal cancers
Lead Applicant: Tomoyuki Tanaka
September 2022
Dentinal fluid movement in response to impression taking for indirect restorations.
Lead Applicant: Andrew Mason
August 2022
Whole genome sequencing of Serratia isolated from patients with bronchiectasis and chronic lung infections
Lead Applicant: James D Chalmers
August 2022
Analysis of the COPD sputum microbiome using stored sputum samples from the Taybridge and TARDIS studies
Lead Applicant: Dr Alison Dicker
August 2022
TR65 Aberdeen Interleukin-27 responses in inflammatory bowel disease - a potential new therapeutic?
Lead Applicant: Dr Sharon King
August 2022
TR196 Aberdeen The role of FGF21 in progression of chronic liver disease
Lead Applicant: Dr Sharon King
August 2022
TR196 Aberdeen The role of FGF21 in progression of chronic liver disease
Lead Applicant: Dr Sharon King
August 2022
TR196 Aberdeen The role of FGF21 in progression of chronic liver disease
Lead Applicant: Dr Sharon King
August 2022
TR155 Aberdeen The role of IL-33 in gastrointestinal fibrosis
Lead Applicant: Dr Sharon King
August 2022
TR155 Aberdeen The role of IL-33 in gastrointestinal fibrosis
Lead Applicant: Dr Sharon King
August 2022
TR65 Aberdeen Interleukin-27 responses in inflammatory bowel disease - a potential new therapeutic?
Lead Applicant: Dr Sharon King
August 2022
Validation of assays for the measurement of neutrophil serine proteases in patients with bronchiectasis
Lead Applicant: James D Chalmers
July 2022
Identification of epigenetic alterations in tumor biopsies of colorectal cancer patients in order to develop predictive biomarkers against anti-EGFR therapy
Lead Applicant: Ana Regina de Abreu
July 2022
Evaluation of EGFR as a therapeutic target in a subgroup of EGFR non-amplified Gastric Cancer (GC) patients
Lead Applicant: Russell Petty
July 2022
Early Colorectal Cancer Detection with the Dxcover Cancer Liquid Biopsy
Lead Applicant: Matthew Baker
July 2022
Surplus Respiratory samples from NHS Immunology & NHS microbiology surplus for future research use
Lead Applicant: James D Chalmers
July 2022
Quality Improvement Project - Breast Tissue Processing
Lead Applicant: Andy Munro
June 2022
Quality Improvement Project - Breast Tissue Processing
Lead Applicant: Andy Munro
June 2022
Exploring mechanisms underlying respiratory and cardiovascular comorbidity in bronchiectasis
Lead Applicant: James D Chalmers
May 2022
Research Tissue Collection-Dundee Dental School and Hospital
Lead Applicant: Mohammad Islam
March 2022
Evaluation of local and systematic immunity in patients with bronchiectasis
Lead Applicant: James D Chalmers
February 2022
CT-scan-based texture analysis and chromosomal copy number variations in renal cancer
Lead Applicant: Ghulam Nabi
February 2022
Developing novel methods to detect lung bacteria in people with bronchiectasis
Lead Applicant: James D Chalmers
January 2022
Developing novel methods to detect lung bacteria in people with bronchiectasis
Lead Applicant: James D Chalmers
January 2022
Development blood assays to support development of a new treatment for P. aeruginosa lung infections
Lead Applicant: James D Chalmers
January 2022
Understanding Exacerbation Phenotypes in COPD
Lead Applicant: James D Chalmers
December 2021
The Role of Inflammatory Markers and Faecal Haemoglobin in Diagnosing Bowel Cancer in Symptomatic Patients
Lead Applicant: Judith Strachan
October 2021
Development of a assay for Tumour neo-antigens to enable personalised cancer immunotherapies
Lead Applicant: Russell Petty
September 2021
Comparison of routine PCR and extraction-less PCR for the diagnosis of gastrointestinal infection
Lead Applicant: Victoria Austin
August 2021
Characterising the adaptive immune response in different clinical phenotypes of aspergillus related lung disease (in patients with non-CF bronchiectasis).
Lead Applicant: James D Chalmers
July 2021
Characterising the adaptive immune response in different clinical phenotypes of aspergillus related lung disease (in patients with non-CF bronchiectasis).
Lead Applicant: James D Chalmers
July 2021
Using Sputum Myeloperoxidase To Identify COPD and Bronchiectasis Subgroups Prone to Exacerbations
Lead Applicant: James D Chalmers
February 2021
Evaluation of Direct Immunofluorescence Staining Techniques for the Diagnosis of Oral Autoimmune Diseases.
Lead Applicant: Sharon White
January 2021
A quantitative comparison between Sox 10 and Melan A immunostaining in chronic sun damaged skin and lentigo maligna.
Lead Applicant: Sharon Edwards
January 2021
CONVICT: Contribution Of Next Generation Sequencing to Understanding Vaccination in COPD Treatment
Lead Applicant: James D Chalmers
January 2021
Investigating airway autoantibodies in bronchiectasis and associated disease severity
Lead Applicant: James D Chalmers
November 2020
Understanding and predicting the evolution of antibiotic resistance in human infection
Lead Applicant: James D Chalmers
November 2020
Validating tumour infiltrating lymphocytes as biomarker of chemotherapy benefit in patients with oesophagogastric cancer recruited to multiple multicentre randomised phase III trials
Lead Applicant: Russell Petty
November 2020
Nucleotide pool measurement in colorectal tissue and PBMC
Lead Applicant: David Harrison
October 2020
Interleukin-6 trans-signalling and its role in COVID19 pathogenesis
Lead Applicant: James D Chalmers
September 2020
Characterising the regulatory signalling networks controlling intestinal T cells
Lead Applicant: Mahima Swamy
August 2020
Metagenomic sequencing of bronchiectasis sputum samples to study the lung microbiome
Lead Applicant: James D Chalmers
August 2020
Potential markers of malignant progression in laryngeal dysplasias
Lead Applicant: Alica Torres
July 2020
Biobanking of RNA and DNA from respiratory tract swabs of patients with suspected Severe acute respiratory syndrome Coronovirus 2 (SARS-CoV2) infection presenting to Ninewells Hospital for next generation sequencing
Lead Applicant: James D Chalmers
March 2020
Assessment of CFTR (cystic fibrosis transmembrane conductance regulator) function across respiratory diseases
Lead Applicant: James D Chalmers
February 2020
Peri-tumoural biomarkers of vascular invasion and nodal metastases in breast cancer-TR000393
Lead Applicant: Samantha Cutler
February 2020
Protease-antiprotease complexes in the airways of patients with bronchiectasis
Lead Applicant: James D Chalmers
February 2020
Setting up of a novel Parallel reaction proteomic assay in snap frozen intestinal biopsies from individuals with and without Inflammatory bowel disease
Lead Applicant: Esther Sammler
February 2020
Generation of a high throughput assay to measure eosinophil extracellular traps (EETs) in human airway secretions to investigate the role of EETs and Neutrophil extracellular traps in treatment response in severe asthma
Lead Applicant: James D Chalmers
January 2020
Contribution of cutaneous SCCs for specialist national tissue collection
Lead Applicant: C Proby
January 2020
Image guided biopsy in oncocytic small renal masses (<4cm): improving diagnostic performance and follow-up outcome study
Lead Applicant: Ghulam Nabi
December 2019
Assessment of intraepidermal nerve fibre density in human breast skin
Lead Applicant: Jane Macaskill
November 2019
Determination of NaV1.5 expression in colon cancer tissue using RNAScope
Lead Applicant: Daniel Baptista-Hon
October 2019
Assessment of the Clinical utility of Aspergillus component resolved diagnostics in patients with sensitisation to Aspergillus
Lead Applicant: Christopher Sevier-Guy
October 2019
Characterisation of topical BET inhibitors in human skin models of eczema
Lead Applicant: Andrew Woodland
September 2019
Human skin explants assay for the assessment of injection site reaction
Lead Applicant: Dr Sharon King
September 2019
The effect of different obduration techniques and sealers, on the root canal filling of oval and round shaped canals and sealer extrusion on periradicular tissues.
Lead Applicant: Dr Ian Robert Ellis
September 2019
Pulpal pressure and dentinal fluid movement in response to impression taking for indirect restorations.
Lead Applicant: Andrew Mason
August 2019
Comparitive Genome Hybridisation (CGH) of exceptional responders to oncological treatment
Lead Applicant: Douglas Adamson
July 2019
Radiomics features using Multiparamteric MR imaging in clinically localised prostate cancer and their association with the expression of hypoxia related genome.
Lead Applicant: chidozie ogbonnaya
May 2019
Exploring clinical relevance of p53 isoforms expression in colon cancer progression
Lead Applicant: jean-christophe bourdon
March 2019
Investigating the tumour promoter role of the Kinase DYRK2 in TNBC
Lead Applicant: Laureano de la Vega
March 2019
iLFT + ELF
Lead Applicant: Dr Jennifer Nobes
February 2019
Identification of unrecognised ciliopathies as a cause of bronchiectasis using next generation sequencing
Lead Applicant: James D Chalmers
January 2019
Biomarkers of inhaled antibiotic response in bronchiectasis
Lead Applicant: James D Chalmers
December 2018
The Role of Nrf2 in Tumour Metabolic Adaptation
Lead Applicant: Albena Dinkova-Kostova
November 2018
Use of Air-Liquid interface cultures of nasal epithelial cells for modelling mucociliary clearance in the airway
Lead Applicant: James D Chalmers
November 2018
Investigating proteinase-antiproteinase balance in bronchiectasis with a focus on pregnancy zone protein
Lead Applicant: James D Chalmers
November 2018
Immunohistochemistry of cancer-associated fibroblasts (CAFs) in ultrasound shear wave elastography (SWE) imaging tissue stiffness for localised prostate cancer
Lead Applicant: wael ageeli
October 2018
Analysis of inter-patient variation in MDR1/ABCB1 expression in ovarian tumour diagnostic biopsies
Lead Applicant: Gillian Smith
September 2018
Use of surplus blood from patients with myeloma to investigate the presence of tumour associated antigens presented on HLA molecules.
Lead Applicant: Dr Simon Powis
September 2018
Epithelial Ovarian Cancer Tissue Microarray
Lead Applicant: Sarah Hawco
September 2018
Investigating Exceptional Responders in Oesophageal Cancer
Lead Applicant: Mark Baxter
September 2018
Quantifying the CFU/mL of Positive Blood Culture and Time to Positivity on SLIC.
Lead Applicant: Dr Ben Parcell
September 2018
Assessment of a New Rapid Molecular Test (Xpert® Xpress Strep A) for the identification of Group A Streptococcus
Lead Applicant: Dr Ben Parcell
August 2018
Evaluating the effect of Photodynamic and Novel Sonodynamic Therapies on Primary and Commercial Glioblastoma Cell Lines
Lead Applicant: Kirit Singh
June 2018
BIOSTAT: Biomarkers of HFpEF and atrial fibrillation project
Lead Applicant: Chim Lang
June 2018
Cancer Ribosomics: comprehensive analysis of ribosome and translation dynamics in cancer
Lead Applicant: Russell Petty
June 2018
Light sheet fluorescence microscopy for histopathology
Lead Applicant: C Simon Herrington
May 2018
EPIC: Exteme phenotypes of COPD genomics
Lead Applicant: COLIN Palmer
May 2018
Diagnostic Usefulness Of Array Based Oncoscan® Analysis In Detecting Copy Number Variations And Differentiating Chromophobe Renal Carcinoma From Oncocytoma.
Lead Applicant: Ghulam Nabi
May 2018
Evaluation of the Idylla method for BRAF mutational analysis in molecular pathology
Lead Applicant: Frank Carey
April 2018
Development of a novel assay to measure Neutrophil Extracellular Traps
Lead Applicant: James D Chalmers
March 2018
Use of blood and sputum samples from patients with respiratory disease that are surplus to diagnostic requirements to test new assays for diagnosing and treating respiratory infections
Lead Applicant: James D Chalmers
March 2018
Abdominoplasty skin samples for investigation of microwave therapy effects: MTAK study
Lead Applicant: C Proby
March 2018
Use of Computer Image Analysis in Diagnosis of Colorectal Adenomatous Polyps and Cancers
Lead Applicant: Stephen McKenna
February 2018
Use of Computer Image Analysis in Diagnosis of Colorectal Adenomatous Polyps and Cancers
Lead Applicant: Stephen McKenna
February 2018
Investigating the Role of Inflammatory Enzymes in the Development of Atherosclerosis and Endothelial Dysfunction
Lead Applicant: Calum Forteath
January 2018
Defining tumoral stromal gene signatures associated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
Lead Applicant: Celine Pourreyron
December 2017
Defining the Clinical Reference Range for the Glyco Liver Profile Test
Lead Applicant: Samuel Beckett
December 2017
CSF biomarkers in Parkinson
Lead Applicant: Esther Sammler
November 2017
relevance of p53 isoforms to human diseases
Lead Applicant: jean-christophe bourdon
September 2017
Does the use of statin improve the outcomes in patients with grade non-muscle invasive urinary bladder cancer (NMIBC) needing intravesical adjuvant BCG?
Lead Applicant: Andrew Symington
August 2017
Proposal to assess depletion of components of the human SWI/SNF complex in clear cell renal carcinoma.
Lead Applicant: Tom Owen-Hughes
July 2017
Blood supply and innervation of the prostate: Improving clinical outcomes of radical prostatectomy
Lead Applicant: Ghazi Alanazi
July 2017
Non-invasive Skin Imaging Following Tissue Irradiation with an Ablative Fractional Laser.
Lead Applicant: Matthew Marzetti
July 2017
Deep learning-based classifier using characteristic signatures in whole genome sequencing of circulating cell-free DNA to identify colorectal cancer, and reliably separate cancer from controls
Lead Applicant: charles roberts
June 2017
Association of erosion/abrasion regiumes on tooth wear and dentine hypersensitivity using imaging and metrology analysis
Lead Applicant: Ryan Olley
May 2017
Next Generation Sequencing of Oesophageal Adenocarcinoma Exceptional Chemotherapy Responders
Lead Applicant: Russell Petty
May 2017
LGR5 in Oesophagel Squamous Cell Carcinoma
Lead Applicant: Russell Petty
May 2017
Investigating EMSY immunostaining in cancer tissues
Lead Applicant: Sara Brown
April 2017
Development of Diagnostic Tests for Protease Biomarkers of Respiratory Disease
Lead Applicant: Kelly Moffitt
March 2017
Development of Diagnostic Tests for Protease Biomarkers of Respiratory Disease
Lead Applicant: Kelly Moffitt
March 2017
Characterisation of EGFR FISH positive Oesophageal Cancer
Lead Applicant: Russell Petty
March 2017
Immunohistochemical and genetic evalaution of neuroendocrine tumours
Lead Applicant: Paul Newey
March 2017
Exploring the role of Neutrophil Extracellular Traps (NETs) in the pathogenesis of Non Alcoholic Fatty Liver Disease (NAFLD)
Lead Applicant: Michael Miller
February 2017
Validation of inflammatory mediators in cutaneous SCC
Lead Applicant: C Proby
January 2017
The pulmonary mycobiome in Bronchiectasis
Lead Applicant: Sanjay Chotirmall
January 2017
Pharmacogenomics in Childhood Asthma
Lead Applicant: Anke H. Maitland-van der Zee
January 2017
Periprostatic Fat Characterisation as a Marker of Prostate Cancer Aggressiveness
Lead Applicant: Naief Dahran
December 2016
Chromosome copy number variation in collecting duct carcinoma
Lead Applicant: Stewart Fleming
December 2016
Pre-clinical evaluation of novel combination therapies for Glioblastoma
Lead Applicant: Kismet Hossain-Ibrahim
December 2016
Pre-clinical evaluation of novel combination therapies for Glioblastoma
Lead Applicant: Kismet Hossain-Ibrahim
December 2016
Pre-clinical evaluation of novel combination therapies for Glioblastoma
Lead Applicant: Kismet Hossain-Ibrahim
December 2016
Pre-clinical evaluation of novel combination therapies for Glioblastoma
Lead Applicant: Kismet Hossain-Ibrahim
December 2016
Development of novel assay to measure disease specific biomarkers in a phase 1 trial of 264RAD therapy
Lead Applicant: Claudia Prevosto
November 2016
Investigating a role of BACE1 in vascular function
Lead Applicant: paul meakin
November 2016
Impact of OCT1 Genotype and OCT1 Inhibiting Drugs on an Individual
Lead Applicant: Laura McCreight
November 2016
Association of intravesical recurrence with ureteroscopic biopsy of upper tract urothelial carcinoma: confirmation of clonal relationship by array-based comparative genomic hybridisation.
Lead Applicant: Thineskrishna Anbarasan
October 2016
Fusion genes in liver cancer
Lead Applicant: Dr Rajai AL-Jehani
October 2016
Proteogenomic Landscaping of Oesophageal Cancer
Lead Applicant: Russell Petty
September 2016
Identification of in-vivo generated human autoantibodies for the screening and early detection of primary colorectal cancer (CRC)
Lead Applicant: Professor John Robertson
September 2016
Cutaneos SCC:Translation from molecular candidates to therapeutic targets
Lead Applicant: Dr Sharon King
August 2016
PPAR delta and COX-2 as predictors of outcome in pancreatic carcinoma
Lead Applicant: Douglas Adamson
July 2016
Proteomic characterisation of the SWI/SNF chromatin remodelling complex in tumour tissue
Lead Applicant: Tom Owen-Hughes
July 2016
Cutaneous SCC: Translation from molecular candidates to therapeutic targets
Lead Applicant: C Proby
July 2016
Cutaneous SCC: Translation from molecular candidates to therapeutic targets
Lead Applicant: C Proby
July 2016
Cutaneous SCC: Translation from molecular candidates to therapeutic targets
Lead Applicant: C Proby
June 2016
Expression of ezrin and related proteins in laryngeal epithlium
Lead Applicant: Kirsty Morley
June 2016
Pharmacokinetics of Metformin Intolerance
Lead Applicant: Laura McCreight
May 2016
Microultrasound characterisation of gastrointestinal tissue
Lead Applicant: Benjamin F Cox
May 2016
Analysis of p53 isoform protein expression in tumours
Lead Applicant: jean-christophe bourdon
May 2016
ICGC breast cancer genome sequencing
Lead Applicant: Colin Purdie
May 2016
Development of a dual immunofluorescence staining method for pro-inflammatory mediators.
Lead Applicant: Ruth Plummer
April 2016
Evaluation of the methodology for isolating and testing circulating tumour DNA
Lead Applicant: David Baty
April 2016
Evaluation of the methodology for isolating and testing circulating tumour DNA
Lead Applicant: David Baty
April 2016
TRIM24 expression in breast cancer
Lead Applicant: Alastair M Thompson
April 2016
TP53 sequencing for patients with chronic lymphocytic leukaemia (CLL)
Lead Applicant: Sudhir Tauro
March 2016
âBiological & Epidemiological insights into HPV related oropharyngeal cancers. The microbial dimension.â
Lead Applicant: David Edwards
March 2016
contract research investigations for dermal bioavailability and toxicology
Lead Applicant: Craig Moore
February 2016
Investigating genetic mechanisms in atopic eczema
Lead Applicant: Sara Brown
February 2016
Studies on isolated fresh gastrointestinal tissues to investigate new medicines
Lead Applicant: David Bunton
February 2016
Structure and composition of bladder cancer organoids
Lead Applicant: Scott Palmer
January 2016
Staining of triple negative breast cancers for TIL markers
Lead Applicant: Frances Fuller-Pace
January 2016
A Feasibility and Method Optimsiation Study in Oesophegal Cancer Proteomics
Lead Applicant: Russell Petty
January 2016
Immunohistochemistry of the synovium, posterior cruciate and meniscofemoral ligaments in the knee joint.
Lead Applicant: MOHAMMAD ALOBAIDY
December 2015
âProfiling the expression of key glycosylation enzymes in pancreatic ductal adenocarcinomas and triple negative breast cancersâ
Lead Applicant: Dr Jennifer Fraser
December 2015
Discrimination of ex-vivo normal colon and colonic adenocarcinoma using combined wavelength-modulated Raman spectroscopy and optical coherence tomography (OCT)
Lead Applicant: C Simon Herrington
December 2015
YAP1 expression in HER2 positive Breast Cancer
Lead Applicant: Beatrix Elsberger
December 2015
Cellular and molecular characterisation of rarer acute myeloid leukaemias
Lead Applicant: Sudhir Tauro
November 2015
Investigating a role of BACE1 in atherosclerosis
Lead Applicant: paul meakin
November 2015
Variation of p53 isoforms rexpression in CLL patients treated by chemotherapy
Lead Applicant: jean-christophe bourdon
October 2015
Studies on isolated fresh skin samples to investigate new medicines
Lead Applicant: David Bunton
October 2015
Identification of metabolic vulnerabilities of renal cell carcinoma
Lead Applicant: Henry Däbritz
September 2015
Periprostatic Fat Characterisation as a Marker of Prostate Cancer Aggressiveness
Lead Applicant: Naief Dahran
September 2015
To assess the clinical performance of a new test for diagnosis of Rheumatoid arthritis
Lead Applicant: Anil Vasishta
September 2015
Validation Cohort: Proteomic and Genomic Analysis of Inflammatory Bowel Disease Associated Colorectal Cancers
Lead Applicant: Dr Shahida Din
August 2015
contract research investigations for dermal bioavailability and toxicology
Lead Applicant: Craig Moore
August 2015
Molecular mechanisms in atopic eczema
Lead Applicant: Sara Brown
August 2015
multibiomaker evaluation of response to radiotherapy in normal breast tissue
Lead Applicant: alastair Thompson
March 2015
Xray diffraction of breast tumours and the peritumoural tissues: a feasibility study
Lead Applicant: Dr Sarah Vinnicombe
January 2015
Measuring downstream targets of ERbeta in breast cancer
Lead Applicant: alastair Thompson
January 2015
YAP1 signalling in HER2 positive breast cancer
Lead Applicant: Beatrix Elsberger
January 2015
Regulation of PIM kinase levels in Chronic Lymphocytic Leukaemia
Lead Applicant: Lucy Littlejohn
January 2015
Osteopontin as a tumour marker of prostatic cancer and the survival rate
Lead Applicant: Abduelmenem Alashkham
January 2015
Sirtuin/nicotinamide adenine dinucleotide pathway: links with inflammation, obesity and colorectal cancer
Lead Applicant: Janice Drew
December 2014
Investigating the role of MSR1 copy number variation in Kalikrein Gene expression in breast cancer.
Lead Applicant: Jonathan Berg
December 2014
Laboratory based isolation and growth of normal skin, breast and adipose cells from redundant tissue
Lead Applicant: C Proby
November 2014
The effect of HLA-Cw6 status on treatment outcome with MTX in psoriasis patients
Lead Applicant: John Foerster
November 2014
Validation of DNA profiling from archival material
Lead Applicant: Stewart Fleming
October 2014
The analysis of novel biomarkers in metastatic melanoma
Lead Applicant: David Meek
October 2014
Molecular Pathogenesis of Cutaneous Squamous Cell Carcinoma - Mutational Profiling of Precursor Lesions
Lead Applicant: Aidan Rose
October 2014
Validation of Biomarker Candidates for Colorectal Cancer Screening
Lead Applicant: Jeffrey Huang
July 2014
Peri-tumoural biomarkers of vascular invasion and nodal metastases in breast cancer
Lead Applicant: andrew evans
July 2014
Improving the rate of detection of histological parameters affecting prognosis in oral squamous cell carcinoma.
Lead Applicant: Richard Oparka
July 2014
Improving the rate of detection of histological parameters affecting prognosis in oral squamous cell carcinoma.
Lead Applicant: Richard Oparka
July 2014
Laboratory based isolation and growth of normal skin, breast and adipose cells from redundant tissue
Lead Applicant: C Proby
July 2014
Perineural spread in head and neck cancer
Lead Applicant: Huda Alkhdar
July 2014
Molecular Pathogenesis of Cutaneous Squamous Cell Carcinoma
Lead Applicant: Aidan Rose
June 2014
Biomarkers of NRF2 activation in NSCLC
Lead Applicant: Kenny MacLeod
June 2014
Studies on isolated fresh diseased colorectal tissue to investigate new medicines
Lead Applicant: David Bunton
June 2014
Investigating a role of BACE1 in inflammatory vascular disease
Lead Applicant: paul meakin
April 2014
Development of molecular therapies for genodermatoses.
Lead Applicant: Irwin McLean
March 2014
Analysis of APAF-1 and DAPK-1 in UT-TCC as correlated with clinical outcome
Lead Applicant: Fionnuala Hinds
March 2014
Genetic mechanisms in eczema pathogenesis
Lead Applicant: Sara Brown
March 2014
Using Low Penetrance Genetic Loci in Colorectal Cancer Screening
Lead Applicant: Jessica Dalzell
February 2014
To confirm the solid tissue staining capabilities of a novel antibody MCM2 in the determination of malignancy in bladder tissue.
Lead Applicant: Bensita Bernard
February 2014
Role of FAM60A in colorectal cancer TR000366-extension
Lead Applicant: Sonia Rocha
January 2014
Investigating the molecular mechanism of anti-NMDA encephalitis
Lead Applicant: Dr Sharon King
January 2014
Supply of residual Clinical Samples for use in the Development of In Vitro Diagnostic Products
Lead Applicant: Peter Kelly
January 2014
Studies on isolated tissues to investigate new medicines
Lead Applicant: David Bunton
January 2014
Procurement of Adipocyte Derived Mesenchymal Cells
Lead Applicant: John Biddlestone
January 2014
Creation of Breast Cancer TMA
Lead Applicant: Frances Fuller-Pace
December 2013
Does the type VII secretory system of Staphylococcus aureus contribute to virulence and colonisation in the skin?
Lead Applicant: Dr. Catriona P.Harkins
December 2013
Molecular Pathogenesis of Cutaneous Squamous Cell Carcinoma
Lead Applicant: Aidan Rose
December 2013
Identification of Tumour-Associated Macrophages in Ovarian Tumours
Lead Applicant: Dr Michael Salako
November 2013
Investigating the Clinicopathological significance of Pim-kinase expression in T-cell non Hodgkinâs lymphoma
Lead Applicant: Maninee Purohit
October 2013
Significance of chromosome 9p deletion in renal cell carcinoma
Lead Applicant: Stewart Fleming
October 2013
ADFP in renal cell carcinoma
Lead Applicant: Stewart Fleming
September 2013
Molecular Pathogenesis of Cutaneous Squamous Cell Carcinoma
Lead Applicant: Aidan Rose
September 2013
G-protein coupled receptors in obesity and metabolic health
Lead Applicant: Janice Drew
September 2013
Scottish Diabetes Research Network: Type 1 Bioresource
Lead Applicant: Helen Colhoun
August 2013
Provision of Gastric Tumour and Normal tissue samples to The Cancer Genome Atlas (TCGA) initiative
Lead Applicant: C Simon Herrington
August 2013
Additional request for TR0168
Lead Applicant: Frank Carey
July 2013
The use of Thiel embalmed cadavers in the evaluation of magnetic resonance imaging guided focused ultrasound surgery (MRgFUS) in the breast: a Feasibility Study
Lead Applicant: Dr Sarah Vinnicombe
July 2013
Sialoadhesin expression and macrophage phenotyping inrenal tissues of patients with anti-neutrophil antibody (ANCA)- associated vasculitis
Lead Applicant: dana kidder
June 2013
Pilot study of auto-antibodies to tumour associated antigens as markers for colorectal cancer
Lead Applicant: Robert Steele
June 2013
Cellular responses to Bendamustine in chronic lymphocytic leukaemia
Lead Applicant: Shubhra Rastogi
June 2013
Expression of novel p68-encoded miRNAs in HER2+ve breast cancer
Lead Applicant: Frances Fuller-Pace
June 2013
Analysis of Hepatitis C Virus Transmission Networks Connecting Urban Centres in Scotland
Lead Applicant: John Dillon
June 2013
Extension of SDH oncocytoma study to include paraganglioma
Lead Applicant: Stewart Fleming
May 2013
Evaluation of anti-IFITM1 antibodies in breast cancer
Lead Applicant: Ted Hupp
May 2013
Expression of PLK1 and p68 in triple negative breast cancers
Lead Applicant: Frances Fuller-Pace
May 2013
Cdk5 activity in human tumours
Lead Applicant: Calum Sutherland
April 2013
Sialoadhesin expression and macrophage phenotyping in renal tissues of patients with anti-neutrophil cytoplasmic antibody (ANCA) âassociated vasculitis
Lead Applicant: dana kidder
April 2013
Validation of microRNA biomarkers in human colorectal tumours and metastases
Lead Applicant: Gillian Smith
April 2013
Investigation of treatment response and relapse in acute promyelocytic leukaemia
Lead Applicant: Richard Dillon
March 2013
Production of normal tissue TMAs
Lead Applicant: Philip Coates
March 2013
Anti-CCP diagnostic assay
Lead Applicant: Karen Anderson
February 2013
Biological and epidemiological insights into HPV related oropharyngeal cancers
Lead Applicant: Athiva Shankar
February 2013
Discrimination of ex-vivo normal skin and basal cell carcinoma using advanced Raman spectroscopy
Lead Applicant: PRAVEEN CHERIYAN ASHOK
February 2013
Investigation of Segmental Overgrowth Disorders
Lead Applicant: Victoria Parker
January 2013
Biomarkers of NRF2 activation in NSCLC
Lead Applicant: Kenny MacLeod
January 2013
Mannose binding lectin deficiency, bacterial infection and disease severity in chronic obstructive pulmonary disease: towards personalised medicine for COPD.
Lead Applicant: COLIN Palmer
January 2013
The role of asparaginyl endopeptidase in EGFR overexpression in head and neck squamous cell carcinoma.
Lead Applicant: Sharon White
January 2013
Significance of Chromosome 9p deletion in renal cell carcinoma
Lead Applicant: Ismail El-Mokadem
January 2013
Discrimination of ex-vivo normal colon and colonic adenocarcinoma using fiber probe based advanced Raman spectroscopy
Lead Applicant: PRAVEEN CHERIYAN ASHOK
January 2013
Comparison of Nicastrin protein expression and p53 mutation status in primary breast cancer
Lead Applicant: alastair Thompson
November 2012
Investigation of p68miRNAs in normal breast tissue
Lead Applicant: Frances Fuller-Pace
November 2012
correlation of cancer cells markers with p53 isoform expression in the Breast Cancer (Roche tumour set)
Lead Applicant: jean-christophe bourdon
October 2012
Immunohistochemical validation of findings from quantative proteomics work in renal cancer (project TR223)
Lead Applicant: Ghulam Nabi
October 2012
Investigating the role of N-WASP in the development and metastasis of colorectal cancer
Lead Applicant: Hayley Morris
September 2012
Characterisation of a recurrent t(1;16) translocation in myeloid malignancy
August 2012
Evaluating tumour sample preservation, integrity and performance: the NeoBIG pilot feasibility Study
August 2012
In-Vivo DNA damage response pathways after IORT for rectal cancer
July 2012
Determining genotypes of potential molar conceptions using Laser micro-dissection of paraffin embedded tissue for Quantitative-fluorescent polymerase chain reaction
July 2012
Does K-Ras mutation status influence 5-FU response?
July 2012
Molecular Pathogenesis of Non-Melanoma Skin Cancers
July 2012
Genes that cause risk of breast cancer - how do polymorphisms affect protein expression in normal and tumour tissue ?
June 2012
Expression of novel p68-encoded miRNAs in breast cancer (
May 2012
Genetic Analysis of the Adenoma-Carcinoma Sequence by Array-CGH
May 2012
The expression and distribution of Wnt signalling components in early and advanced cutaneous SCC-stages.
May 2012
Identification of novel genes in malignant melanoma
May 2012
Molecular signatures for prediction of porgnosis
April 2012
Clinical and patient-reported outcomes in patients with HPV and non HPV related head and neck cancer
April 2012
Case Collections and genetic Analysis of Hidradenitis Suppurativa and Acne Vulgaris
April 2012
Identification and Validation of Novel Genes Involved in HDL Metabolism
March 2012
Exome chip genotyping in the search for COPD susceptibility variants
March 2012
Immunochemistry of gammaH2AX expression after radiotherapy for rectal cancer
March 2012
Clinical and patient-reported outcomes in patients with HPV and non HPV related head and neck cancer: combining immunohistochemistry, routine data linkage and touch screen technology
February 2012
Analysis of Rapid Protein Turnover in Human Tissues
February 2012
Discrimination of ex-vivo normal colon and colonic adenocarcinoma using advanced Raman spectroscopy
February 2012
The role of BCL9 in human HCC
January 2012
Analysis of low frequency coding variants in cardiometabolic traits
January 2012
Is Neutrophil Gelatinase-Associated Lipocalin (NGAL) a Prognostic or Diagnostic Marker for Oral Cancer?
January 2012
Head and neck cancer prognostic study using a quantitiative malignancy index diagnostic system on retrospective archival FFPE tissue
January 2012
p68 and SNIP1 expression in breast cancer and association with cyclin D1 status
January 2012
Expression of PTOV1 in Prostate Cancer
January 2012
ICGC breast cancer genome sequencing
November 2011
Wnt5a in SCC and BCC
November 2011
Hepatitis C virus effect on cancer gene alternative splicing
November 2011
Validating different methods of extracting small RNAs from breast cancer tissues
November 2011
Pilot study to compare gene expression in matched primary colorectal tumours and liver metastases
October 2011
Variant HER-2/CEP17 FISH patterns and associated chromosome abnormalities in breast cancer
October 2011
Normal/tumour differences in miRNA expression in human colorectal tumours
September 2011
Expression of novel p68-encoded miRNAs in breast cancer
September 2011
Adrenal expression of corticosteroid-producing enzymes and associated regulatory molecules.
August 2011
Analysis of HE4 Expression by Immunohistochemistry in FFPE Derived Breast Tumours with BRCA1 Mutation
August 2011
An extension of TR000119 to investigate the role of TES in Breast Cancer.
August 2011
breast cancer genome project
August 2011
Breast Cancer Genome project
August 2011
Validation studies in Haemopoietic Malignancies
August 2011
A preliminary study into the prevalence of respiratory Mycoplasma infections in Tayside
July 2011
A pilot investigation into the feasibility of developing a record-linked database to study the genetics of childhood eczema in primary care
July 2011
Identification of microRNA signatures in colorectal tumours and adenomas
June 2011
Histological evaluation of LKB1 protein expression in primary breast cancer
June 2011
Tissue Bank application for Analysis of HCV treatment Outcomes
June 2011
Actin cytoskeleton remodelling is essential for cutaneous squamous cell carcinoma dissemination
June 2011
Identifying Ovarian Cancers with Loss of BRCA1
June 2011
Expression Profile of Lymphocyte-activation Markers in T-cell non-Hodgkins Lymphoma Responsive to Immune Modulation.
May 2011
Expression of CYP2C8 in lung
April 2011
An extension of Tayside Tissue Bank TR0063 project to explore the relationship between genotype at low-penetrance risk loci, and breast cancer phenotype and outcome.
April 2011
Eosinophillic oesophagitis: An immunohistochemical study of lymphocyte populations in adult and paediatric patients.
April 2011
The p53 2011 project
April 2011
Expression of SNIP1 in cancer tissues
March 2011
Phosphorylation of the p68 RNA helicase in cancer tissues
March 2011
Assessment and validation of in vitro systems for evaluating drug metabolic pathways involving glucuronidation and sulfation
March 2011
The role of OATP1B3 as a therapeutic target in RDEB SCC
March 2011
Expression of Polo-like kinase-1 in breast tumours: correlation with p53 status
January 2011
Genomic characterisation of myelodysplastic syndromes
January 2011
Expression of Mage-A antigens in breast cancer and relationship with p53 status
January 2011
Whole genome sequencing of papillary renal carcinoma
December 2010
Significance of chromosome 9p status in small renal masses
December 2010
The Molecular Pathology of Differentiated Type VIN and Invasive Vulvar Squamous Cell Carcinoma
November 2010
Antibody Validation for MRFAP Using Human Tissue Lysates.
November 2010
Analysis of FOXL2 mutation in gynandroblastomas
November 2010
Prognostic impact of LAIR-1 expression in diffuse large B-cell lymphoma
November 2010
Role of FMN2 in cancer
November 2010
11 beta hydroxysteroid dehydrogenase 2 in tumour angiogenesis
October 2010
Quantitative proteomics analysis in renal cancer
October 2010
WGA of DNA from Colorectal Lesions for ACGH analysis
September 2010
Expression of LRH-1 isoforms in breast cancer
September 2010
Go-DARTs study of diabetes, treatment and outcome.
September 2010
Characterisation of colon pathology by cell marker multiplex with the GenomeLab System
August 2010
Detection of bladder cancer cells in sections using Raman spectroscopy.
August 2010
Analysis of mechanism of initiation of APC wild type adenomas
August 2010
Comparison of gene expression in fresh frozen and FFPE ovarian tumours
August 2010
Sub-microscopic genomic assessment of morphologically atypical variants of acute promyelocytic leukaemia: alter idem or acute myeloid leukaemia with t(15;17)?
July 2010
High-resolution analysis of the neoplastic genome in long-term survivors of minimally-treated elderly acute lymphoblastic leukaemia (a pilot study)
July 2010
Microsatellite instability in collecting duct carcinoma of the kidney
May 2010
Amendment to: The expression of peroxisome proliferator-activated receptor gamma (PPARg) in breast and upper gastro-intestinal cancer.
May 2010
Angiotensinogen promotor polymorphisms and the risk of renal cancer progression
May 2010
X inactivation ratios in normal liver
May 2010
Development of molecular therapies for genodermatoses.
April 2010
A Comparative Evaluation of 3 Human Tissue RNA Extraction Methods
April 2010
p53 mutation and gene expression after chemotherapy
April 2010
ChIP of WT1 on ovarian carcinoma
March 2010
The characterisation of telomere dynamics in Myelodysplastic syndrome
February 2010
Role of RCC1 in genomic instability in diffuse large B and follicular lymphomas
January 2010
Immunohistochemical detection of phospho-epitopes - the effect of tissue ischaemia
January 2010
Application of next generation sequencing to interrogate the transcriptome of atopic skin.
January 2010
Diagnostic Markers for Detection and Monitoring of Oesophageal Disease
December 2009
The expression of peroxisome proliferator-activated receptor gamma (PPARg) in breast and upper gastro-intestinal cancer.
December 2009
Role of RCC1 in genomic instability in diffuse large B and follicular lymphomas
December 2009
Improving the diagnostic yield from axillary node core biopsies in breast cancer patients
November 2009
Oncogenic actions of WT1 on adult neoplasms
November 2009
To develop a cDNA array as a predictive tool for chemoresistance in ovarian cancer
November 2009
Mechanisms of imiquimod induced regression in lentigo maligna
November 2009
Identification of novel genes in malignant melanoma
November 2009
Optical Projection Tomography in Colorectal Polyps
November 2009
Oncoprotein expression in salivary gland tumours
November 2009
Does membrane ER existence in human breast cancers?
October 2009
Identification of novel genes in malignant melanoma
October 2009
CBX8 expression in breast cancer
September 2009
CAncer associated small tRNAs as potential diagnostic tools
September 2009
The APC protein in early tissue changes in gut cancer
September 2009
Early tissue changes in intestinal cancer
September 2009
Detection of phenthiazinium dye derivative in human skin by microscopy.
August 2009
Creation of a tissue microarray for the analysis of prognostic factors in male breast cancer
July 2009
The potential association between germline mutations of microRNA 125a and breast cancer
July 2009
High-resolution imaging combined with conventional systems for improved diagnostic medical ultrasound imaging
June 2009
Identification of novel targets for colorectal cancer using scFV phage display applied to an ex-vivo human organ perfusion system.
June 2009
Expression of Polo-like kinase-1 in breast tumours: correlation with p53 status
May 2009
Test request please ignore
May 2009
PPARdelta signalling in Breast Cancer
May 2009
Genetic determinants of type 2 diabetes, susceptibility, related disease outcomes and response to therapy
May 2009
Barrett's Oesophagus Biomarker study
May 2009
The secretory component receptor: a novel trigger of eosinophil responses in asthma
May 2009
Genomic analysis of human NASH
May 2009
DUSP-9 a marker of hepatic neoplasia?
May 2009
EXPRESSION OF MAGE-A ANTIGENS IN BREAST CANCER AND RELATIONSHIP WITH P53 STATUS
April 2009
Biophotonics approaches to the diagnosis of anogenital neoplasia
April 2009
Investigating the presence of migration-stimulating factor (MSF) within the haematopoietic and lymphoid microenvironment
April 2009
Mechanisms of IQGAP2 gene silencing in hepatic carcinogenesis
March 2009
A Screening Test for Colorectal Cancer
March 2009
Molecular Pathogenesis of Non-Melanoma Skin Cancers
March 2009
Identification of novel genes in melanoma
March 2009
Identification of novel genes in melanoma
March 2009
The value of Interleukins(IL) in predicting the outcome of head and neck cancer
February 2009
Microsatellites and linkage analysis to determine specimen collection error rates in a diagnostic laboratory
February 2009
Laboratory based isolation and growth of normal skin and adipose cells from redundant tissue.
February 2009
BRCA1 Polymorphisms and Mutations in Triple Negative Breast Cancer
February 2009
The role of Protein Tyrosine Phosphatase Receptor Delta in Squamous Cell Skin Cancers
January 2009
Maladaption of Nrf2 to Oxidative stress in the liver
December 2008
Investigating the Molecular Response to IORT in Colorectal Cancer
December 2008
Molecular pathogenesis of non−melanoma skin cancers
December 2008
Highly Accurate Breast Cancer Diagnosis through Integration of Biological Knowledge, Novel Imaging Modalities, and Modelling (HAMAM) Cohort 1 analysis of breast cancer imaging data in combination with clinical, pathological and genetic information.
December 2008
Assessing the frequency and significance of t(7;21)(p22;q22) in acute myeloid leukaemia and myelodysplastic syndromes (Collaborative Study with West Midlands Tissue Bank)
November 2008
The function of p63 in B-cell lymphomas
October 2008
ERM (ezrin, radixin, moesin) proteins in oral squamous cell carcinoma
October 2008
Studies of Selected Isolated Human Tissues for Identification of Efficacy, Potency and Mechanisms of Action of Pharmacological Agents
September 2008
Why are cystic fibrosis airways inflamed? Insight into a potential mechanism.
September 2008
GenomeLab GeXP assay of cancer gene targets
August 2008
Molecular analysis of the tumour suppressor gene, TES, in human breast cancer
July 2008
High-resolution imaging combined with conventional systems for improved diagnostic medical ultrasound imaging
July 2008
Laminin 332 processing in squamous cell carcinoma
July 2008
Molecular analysis of the tumour suppressor gene, TES, in human breast cancer
July 2008
The Role of Proteomics in Colorectal Cancer Screening
July 2008
HOX genes in head and neck cancer
July 2008
Filensin expression in Breast Cancer Tissue
July 2008
DNA / RNA Extraction for Tayside Tissue Bank
July 2008
Stoichiometry of phosphorylation of Akt in breast tumours
July 2008
Validation of K-Ras gene amplification in colorectal tumours - comparison with normal tissue
June 2008
Microarray analysis of tamoxifen treated breast cancer
June 2008
Sialodehsin positive macrophage in immune-mediated glomerulonephritis
May 2008
Pin1 expression in Breast cacner
May 2008
SDH mutations in renal oncytoma
May 2008
Hox genes in Head and Neck Cancer
April 2008
A Multi-centric Study of Intracellular Protein Expression in Subcutaneous Panniculitis-like T-cell Lymphoma: Potential for Bio-marker-based Treatment Strategies?
April 2008
Endoglin methylation in breast cacner
April 2008
Accessing anti-centromere antibody positive human serum for use as a research tool.
April 2008
Extension of previous studies into the in vitro response of acute myeloid leukaemia to rimcazole
April 2008
Further validation of biomarkers for molecular sub-classification of colorectal cancer patients
March 2008
Expression of Mage-A antigens in breast cancer and relationship with p53 status
March 2008
Oral cancer and pre-cancer: a retrospective study of markers of disease progression and the role of Human Papilloma Virus
March 2008
CYP450 polymorphisms and tamoxifen treatment in breast cancer
March 2008
Correlation of Transforming Growth factor Beta (TGF-β) and related signaling signatures with breast cancer tumour grade, prognosis and metastasis.
March 2008
Effects of high dose UVA1 phototherapy on cutaneous fibrosis and endothelial cell function in patients with systemic sclerosis
February 2008
A pilot PCR bacterial analysis of resected liver specimens
February 2008
Analysis of mammary tumour models
January 2008
PAS proteins in basal cell carcinoma
January 2008
PAS proteins in basal cell carcinoma
January 2008
Beta-papillomaviruses and immunocompetent keratinocyte skin cancers: Is vaccination feasible?
January 2008
expression of p53 isoforms in liver metastasis derived from colon primary tumour
January 2008
Evaluation of Optical Projection Tomography (OPT) as a diagnostic tool
December 2007
Langerhans cell rich mycosis fungoides
November 2007
Role of Dendritic Cells in the Development of Cutaneous Pseudolymphoma and Cutaneous Marginal Zone Lymphoma
November 2007
ERM proteins in hyperproliferative epithelial disorders associated with HPV infection
November 2007
Linking cytogenetic abnormalities to p53 mutations and clinical outcome in breast cancer
November 2007
Molecular profiling of ovarian tumours - implications for personalised medicine
November 2007
RNA extraction from renal tumours
November 2007
Investigation of TGF-beta signaling in Human Umbilical vein Endothelial Cells
October 2007
Investigating the role of polymorphisms, inluding those in FGFR2, TNRC9 and MAP3KI in breast cancer risk and progression
October 2007
Does RCC1 overexpression dysregulate the spindle attachment checkpoint and promote chromosome instability?
October 2007
Epigenetic targeting of chronic lymphocytic leukaemia in a pre-clinical model
September 2007
Implications of cytochrome P450s for Breast Cancer Development and anti-Cancer Therapy
September 2007
Evaluation of Cytochrome P450 CYP1 and CYP2 protein expression in lung tumour and normal tissue
September 2007
Evaluation of Cytochrome P450 CYP1 and CYP2 protein expression in lung tumour and normal tissue
September 2007
: Analysis of novel genetic and epigenetic changes in breast cancer and identification of novel genotype/ epigenotype: clinical phenotype correlations in breast cancer.
September 2007
Analysis of sep53/cornulin mutations in adenocarcinoma of the oesophagus and squamous carcinoma of the oesophagus
September 2007
Analysis of DUSP9 / Pyst3 expression in endoderm-derived visceral organ tumours
July 2007
Analysis of DUSP9 / Pyst3 expression in endoderm-derived visceral organ tumours
July 2007
Analysis of DUSP9 / Pyst3 expression as a novel predictor of outcome in primary hepatic tumours
July 2007
Elucidating Interactions of Systems that Mediate Xenobiotic Disposition:
July 2007
The role of common genetic variation in breast cancer susceptibility and therapuetic response
July 2007
Investigation of patterns of x chromosome inactivation in different tissues
June 2007
Investigation of patterns of x chromosome inactivation in different tissues
June 2007
CRYAB levels in sera from breast cancer patients
May 2007
Investigating the TGF-Beta Signalling pathway as a modifier for predisposition to breast cancer, and clinical outcome.
May 2007
Oncogenic actions of WT1
May 2007
cMyc:Peroxiredoxin regulation in haemopoiesis
April 2007
Pilot study to determine whether human skin expresses certain proteins
April 2007
Vasculogenesis in Head and Neck Squamous Cell Carcinoma
March 2007
Pilot study to evaluate vascular responses and phospholemman
March 2007
Computed tomography guided fine needle aspiration of lung- does ThinPrep assist?
January 2007
Preclinical study of Med BioGenes Custom 16-Assay Bioarray for subtyping Leukemia and Lymphoma
December 2006
p53 pathway in tumours
November 2006
Identification and validation of biomarkers for molecular sub-classification of colorectal cancer patients implications for personalised medicine
November 2006
Analysis of mammary tumour models
October 2006
Gene expression profiling in colorectal cancer
September 2006
Molecular Signatures of Normal Breast Tissues
September 2006
NF-kB expression in breast cancer and breast stroma
July 2006
